Professor Fidelma Flanagan:

No. It is an exponential. I would point to the element of family history, however. Hereditary breast cancers turn up in the very young age group. That is another strategy that we are looking at. In our symptomatic service, we already provide family history clinics. As we talked about earlier, however, we must strengthen that area with screening and by improving surveillance. The percentage of women presenting in their 30s will perhaps have a greater likelihood of having a genetic predisposition and we must be able to provide a good service for those women.